• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与肝细胞核因子1α失活相关的家族性肝腺瘤病

Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation.

作者信息

Bacq Yannick, Jacquemin Emmanuel, Balabaud Charles, Jeannot Emmanuelle, Scotto Beatrice, Branchereau Sophie, Laurent Christophe, Bourlier Pascal, Pariente Daniele, de Muret Anne, Fabre Monique, Bioulac-Sage Paulette, Zucman-Rossi Jessica

机构信息

Department of Hepatogastroenterology, Centre Hospitalier de Tours, Hôpital Trousseau, 37044 Tours Cedex, France.

出版信息

Gastroenterology. 2003 Nov;125(5):1470-5. doi: 10.1016/j.gastro.2003.07.012.

DOI:10.1016/j.gastro.2003.07.012
PMID:14598263
Abstract

BACKGROUND & AIMS: Germline mutations in hepatocyte nuclear factor 1alpha (TCF1/HNF-1alpha) are associated with maturity-onset diabetes of the young type 3 (MODY3), and somatic biallelic inactivations of the gene are found in hepatocellular adenomas and liver adenomatosis. This study investigated cosegregation of HNF-1alpha germline mutations with diabetes and liver adenomatosis in 2 families.

METHODS

Two unrelated patients with liver adenomatosis and harboring HNF-1alpha germline and somatic mutations were studied. Subsequently, we screened 9 relatives in the 2 independent families for diabetes, hepatocellular adenomas, and HNF-1alpha germline mutations.

RESULTS

In family A, a father and his son presented with an intraperitoneal hemorrhagic rupture of a liver adenomatosis without diabetes. A heterozygous R229X germline mutation was identified in HNF-1alpha in the father and his son and also in his second 27-year-old son without hepatocellular adenomas. In family B, a diagnosis of liver adenomatosis was made fortuitously in a 14-year-old girl. A heterozygous G55fsX57 germline mutation in HNF-1alpha was identified in this patient, her diabetic father, and her 2 sisters. Systematic exploration showed liver adenomatosis in the 2 sisters. Somatic inactivation of the second HNF-1alpha allele was found in liver tumors in both families.

CONCLUSIONS

This study describes familial liver adenomatosis and shows the association with germline HNF-1alpha mutations in adults and children. It also highlights the importance of screening for hepatocellular adenomas, diabetes, and HNF-1alpha germline mutations in relatives of patients with liver adenomatosis. Finally, prevalence of liver adenomatosis remains to be evaluated in MODY3 subjects.

摘要

背景与目的

肝细胞核因子1α(TCF1/HNF-1α)的种系突变与青年型3型成年发病型糖尿病(MODY3)相关,并且在肝细胞腺瘤和肝腺瘤病中发现该基因的体细胞双等位基因失活。本研究调查了2个家系中HNF-1α种系突变与糖尿病和肝腺瘤病的共分离情况。

方法

研究了2例患有肝腺瘤病且携带HNF-1α种系和体细胞突变的无关患者。随后,我们在这2个独立家系中筛查了9名亲属是否患有糖尿病、肝细胞腺瘤以及HNF-1α种系突变。

结果

在A家系中,一名父亲及其儿子出现了肝腺瘤病的腹腔内出血破裂,但无糖尿病。在父亲及其儿子以及其27岁未患肝细胞腺瘤的次子中,均鉴定出HNF-1α的杂合R229X种系突变。在B家系中,一名14岁女孩偶然被诊断为肝腺瘤病。在该患者、其患糖尿病的父亲及其2个姐妹中,均鉴定出HNF-1α的杂合G55fsX57种系突变。系统检查发现这2个姐妹患有肝腺瘤病。在两个家系的肝肿瘤中均发现了第二个HNF-1α等位基因的体细胞失活。

结论

本研究描述了家族性肝腺瘤病,并显示了其与成人和儿童HNF-1α种系突变的关联。它还强调了对肝腺瘤病患者亲属进行肝细胞腺瘤、糖尿病和HNF-1α种系突变筛查的重要性。最后,MODY3患者中肝腺瘤病的患病率仍有待评估。

相似文献

1
Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation.与肝细胞核因子1α失活相关的家族性肝腺瘤病
Gastroenterology. 2003 Nov;125(5):1470-5. doi: 10.1016/j.gastro.2003.07.012.
2
Hepatocyte nuclear factor-1 alpha gene inactivation: cosegregation between liver adenomatosis and diabetes phenotypes in two maturity-onset diabetes of the young (MODY)3 families.肝细胞核因子-1α基因失活:两个青年发病的成年型糖尿病(MODY)3家系中肝腺瘤病与糖尿病表型的共分离。
J Clin Endocrinol Metab. 2004 Mar;89(3):1476-80. doi: 10.1210/jc.2003-031552.
3
Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels.MODY3基因肝细胞核因子-1α对载脂蛋白M基因表达的调控:单倍剂量不足与血清载脂蛋白M水平降低相关。
Diabetes. 2003 Dec;52(12):2989-95. doi: 10.2337/diabetes.52.12.2989.
4
Identifying hepatic nuclear factor 1alpha mutations in children and young adults with a clinical diagnosis of type 1 diabetes.在临床诊断为1型糖尿病的儿童和青年中鉴定肝细胞核因子1α突变。
Diabetes Care. 2003 Feb;26(2):333-7. doi: 10.2337/diacare.26.2.333.
5
Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4.青少年发病的成年型糖尿病及早发型非胰岛素依赖型糖尿病中肝细胞核因子-1α基因的突变:外显子4存在突变热点的证据
Diabetes. 1997 Mar;46(3):528-35. doi: 10.2337/diab.46.3.528.
6
Bi-allelic inactivation of TCF1 in hepatic adenomas.肝腺瘤中TCF1的双等位基因失活。
Nat Genet. 2002 Oct;32(2):312-5. doi: 10.1038/ng1001. Epub 2002 Sep 23.
7
A low renal threshold for glucose in diabetic patients with a mutation in the hepatocyte nuclear factor-1alpha (HNF-1alpha) gene.肝细胞细胞核因子1α(HNF-1α)基因发生突变的糖尿病患者存在较低的肾糖阈。
Diabet Med. 1998 Oct;15(10):816-20. doi: 10.1002/(SICI)1096-9136(199810)15:10<816::AID-DIA714>3.0.CO;2-P.
8
Analysis of a non-functional HNF-1alpha (TCF1) mutation in Japanese subjects with familial type 1 diabetes.对日本家族性1型糖尿病患者中一种无功能的肝细胞核因子-1α(TCF1)突变的分析。
Hum Mutat. 2001 Oct;18(4):345-51. doi: 10.1002/humu.1196.
9
Liver adenomatosis in patients with hepatocyte nuclear factor-1 alpha maturity onset diabetes of the young (HNF1A-MODY): Clinical, radiological and pathological characteristics in a French series.年轻起病的成人型糖尿病 1 型(HNF1A-MODY)患者的肝腺瘤病:法国系列的临床、放射学和病理学特征。
J Diabetes. 2020 Jan;12(1):48-57. doi: 10.1111/1753-0407.12959. Epub 2019 Jul 10.
10
Identification and functional characterization of a novel mutation of hepatocyte nuclear factor-1alpha gene in a Korean family with MODY3.一个韩国MODY3家系中肝细胞核因子-1α基因新突变的鉴定与功能特征分析
Diabetologia. 2003 May;46(5):721-7. doi: 10.1007/s00125-003-1079-7. Epub 2003 Apr 24.

引用本文的文献

1
Genomic and Transcriptomic Profile of HNF1A-Mutated Liver Adenomas Highlights Molecular Signature and Potential Therapeutic Implications.HNF1A 突变肝腺瘤的基因组和转录组特征突出了分子特征和潜在的治疗意义。
Int J Mol Sci. 2024 Sep 29;25(19):10483. doi: 10.3390/ijms251910483.
2
Genetics of liver disease in adults.成人肝脏疾病的遗传学。
Hepatol Commun. 2024 Mar 29;8(4). doi: 10.1097/HC9.0000000000000408. eCollection 2024 Apr 1.
3
Pediatric Hepatocellular Adenomas: What Is Known and What Is New?小儿肝细胞腺瘤:已知与新知
Cancers (Basel). 2023 Sep 29;15(19):4790. doi: 10.3390/cancers15194790.
4
Benign liver tumours: understanding molecular physiology to adapt clinical management.良性肝肿瘤:了解分子生理学以适应临床管理。
Nat Rev Gastroenterol Hepatol. 2022 Nov;19(11):703-716. doi: 10.1038/s41575-022-00643-5. Epub 2022 Jul 14.
5
Hepatocellular adenoma: Where are we now?肝细胞腺瘤:我们现在在哪里?
World J Gastroenterol. 2022 Apr 14;28(14):1384-1393. doi: 10.3748/wjg.v28.i14.1384.
6
Disruption of Tumor Suppressors HNF4α/HNF1α Causes Tumorigenesis in Liver.肿瘤抑制因子HNF4α/HNF1α的破坏导致肝脏肿瘤发生。
Cancers (Basel). 2021 Oct 26;13(21):5357. doi: 10.3390/cancers13215357.
7
Genetic and epigenetic basis of hepatoblastoma diversity.肝癌多样性的遗传和表观遗传基础。
Nat Commun. 2021 Sep 20;12(1):5423. doi: 10.1038/s41467-021-25430-9.
8
Case Report: Hepatic Adenoma in a Child With a Congenital Extrahepatic Portosystemic Shunt.病例报告:一名患有先天性肝外门体分流的儿童的肝腺瘤
Front Pediatr. 2020 Aug 25;8:501. doi: 10.3389/fped.2020.00501. eCollection 2020.
9
Hepatocellular adenoma in the paediatric population: Molecular classification and clinical associations.儿童肝腺瘤:分子分类和临床关联。
World J Gastroenterol. 2020 May 21;26(19):2294-2304. doi: 10.3748/wjg.v26.i19.2294.
10
New insights in the management of Hepatocellular Adenoma.肝细胞腺瘤的治疗新视角。
Liver Int. 2020 Jul;40(7):1529-1537. doi: 10.1111/liv.14547. Epub 2020 Jun 11.